Assessment of Tubigrip Versus Plaster of Paris in the Treatment of Grade 1 and 2 Lateral Ankle Sprains
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 200
- Locations
- 2
- Primary Endpoint
- pain, karlsson score
Study Overview
Brief Summary
Until now very few studies have been done to compare the efficacy of tubigrips or plaster of paris in the treatment of lateral ankle sprains, the investigators aim to compare the tubigrip against plaster of paris in the treatment of lateral ankle sprains.
Detailed Description
200 patients were enrolled after meeting inclusion criteria.All patients gave the verbal as well as written consent for inclusion in the study. The hospital committee ethical review board gave the permission for this study. Only 126 patients agreed to participate in the study. After informed consent was obtained the patients were randomized such that each patient was allocated to use either a Tubigrip (Group A) or Plaster of Paris (Group B)using the Block randomization. The patients in TG group receive the Tubigrip treatment and the patients in POP group were given a below knee plaster cast. Patients were instructed to follow up at 2 weeks and then at 6 weeks. The functional score and pain were used as outcomes of the study
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to 40 Years (Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •age 18-40 years
- •grade 1 and 2 ankle sprains
- •permanent residents in place of study
- •no concomitant bone pathology
- •have not been recruited in other trial simultaneously
Exclusion Criteria
- •Patients with age <18 years
- •injury >48 hours, fractures
- •multiple injuries
- •any neurological or musculoskeletal illness
- •any co-morbid associated with long term disabilities
- •grade 3 lateral ankle sprains
Outcomes
Primary Outcomes
pain, karlsson score
Time Frame: 6 weeks
Secondary Outcomes
No secondary outcomes reported